MUNSHI AMIT purchased 365K shares of INHIBIKASE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $500.1K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 10/23/2024ACC: 0000950170-24-116780
+425K
Net shares
Net buyer
$500.1K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
425K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+365K
Price / share
$1.37
Trade value
$500.05K
% of position
New position
10/21/2024
0.00→365K
Total
Net shares
+365K
Net value
$500.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/21/2024 | P · Purchase | +365K | $1.37 | $500.05K | New position | 0.00 | 365K |
| Total | +365K | $500.05K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
60K shares
Shares
+60K
Strike price
2.22
Held after
60K
Exercisable
—
10/21/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock60K shares | 10/21/2024 | A · Award | +60K | 2.22 | — | 60K |